Literature DB >> 19107755

Is a preserved functional reserve a mechanism limiting clinical impairment in pediatric MS patients?

Maria A Rocca1, Martina Absinta, Angelo Ghezzi, Lucia Moiola, Giancarlo Comi, Massimo Filippi.   

Abstract

We evaluated the functional magnetic resonance imaging (fMRI) correlates of simple movement performance in patients with pediatric multiple sclerosis (MS) and their relation with the extent of T2 lesion volume (LV), to improve our understanding of the mechanisms leading to their short/medium term favorable clinical course. We obtained fMRI during repetitive flexion-extension of the last four fingers of the right hand and brain dual-echo scans from 17 right-handed patients with pediatric relapsing-remitting MS and 9 sex- and age-matched right-handed healthy controls. T2 LV was measured using a local thresholding segmentation technique. fMRI activations and functional connectivity analysis were performed using SPM2. Compared to controls, pediatric MS patients had an increased recruitment of the left (L) primary sensorimotor cortex (SMC). They also showed reduced functional connectivity between the L primary SMC and the L thalamus (P = 0.03), the L insula and the L secondary sensorimotor cortex (SII) (P = 0.02), the supplementary motor area and the L SII (P = 0.02), the L thalamus and the L insula (P = 0.01) and the L thalamus and the L SII (P = 0.003). In patients with pediatric MS, the activity of the L primary SMC was significantly correlated with brain T2 LV (r = 0.78). No correlation was found between coefficients of abnormal connectivity and structural MRI measures. The maintenance of a selective and strictly lateralized pattern of movement-associated brain activations and a modulation of its functional connections suggest a preserved functional reserve in patients with pediatric MS, which, in turn, might contribute to explain their favorable clinical evolution at short/medium term. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19107755      PMCID: PMC6871244          DOI: 10.1002/hbm.20712

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  34 in total

1.  Normalized accurate measurement of longitudinal brain change.

Authors:  S M Smith; N De Stefano; M Jenkinson; P M Matthews
Journal:  J Comput Assist Tomogr       Date:  2001 May-Jun       Impact factor: 1.826

2.  Aging is associated with contrasting changes in local and distant cortical connectivity in the human motor system.

Authors:  James B Rowe; Hartwig Siebner; Sasa R Filipovic; Carla Cordivari; Willibald Gerschlager; John Rothwell; Richard Frackowiak
Journal:  Neuroimage       Date:  2006-06-21       Impact factor: 6.556

3.  Dynamic causal modelling.

Authors:  K J Friston; L Harrison; W Penny
Journal:  Neuroimage       Date:  2003-08       Impact factor: 6.556

Review 4.  The neural substrates of motor recovery after focal damage to the central nervous system.

Authors:  Nick S Ward
Journal:  Arch Phys Med Rehabil       Date:  2006-12       Impact factor: 3.966

5.  MRI features of pediatric multiple sclerosis.

Authors:  B Banwell; M Shroff; J M Ness; D Jeffery; S Schwid; B Weinstock-Guttman
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

6.  Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage.

Authors:  Maria A Rocca; Andrea Falini; Bruno Colombo; Giuseppe Scotti; Giancarlo Comi; Massimo Filippi
Journal:  Ann Neurol       Date:  2002-03       Impact factor: 10.422

Review 7.  Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions.

Authors:  Brenda Banwell; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu
Journal:  Lancet Neurol       Date:  2007-10       Impact factor: 44.182

8.  Functional cortical changes of the sensorimotor network are associated with clinical recovery in multiple sclerosis.

Authors:  Domenico M Mezzapesa; Maria A Rocca; Mariaemma Rodegher; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2008-05       Impact factor: 5.038

9.  Natural history of multiple sclerosis with childhood onset.

Authors:  Christel Renoux; Sandra Vukusic; Yann Mikaeloff; Gilles Edan; Michel Clanet; Bénédicte Dubois; Marc Debouverie; Bruno Brochet; Christine Lebrun-Frenay; Jean Pelletier; Thibault Moreau; Catherine Lubetzki; Patrick Vermersch; Etienne Roullet; Laurent Magy; Marc Tardieu; Samy Suissa; Christian Confavreux
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

Review 10.  Functional MRI in multiple sclerosis.

Authors:  Maria A Rocca; Massimo Filippi
Journal:  J Neuroimaging       Date:  2007-04       Impact factor: 2.486

View more
  12 in total

1.  Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis.

Authors:  Maria A Rocca; Paola Valsasina; Martina Absinta; Lucia Moiola; Angelo Ghezzi; Pierangelo Veggiotti; Maria P Amato; Mark A Horsfield; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2014-02-07       Impact factor: 5.038

Review 2.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

Review 3.  Cognitive impairment in pediatric multiple sclerosis.

Authors:  A Ghezzi; B Goretti; E Portaccio; M Roscio; M P Amato
Journal:  Neurol Sci       Date:  2010-11       Impact factor: 3.307

4.  Thalamocortical sensorimotor circuit in multiple sclerosis: an integrated structural and electrophysiological assessment.

Authors:  Maria Luisa Dell'Acqua; Doriana Landi; Giancarlo Zito; Filippo Zappasodi; Domenico Lupoi; Paolo M Rossini; Maria M Filippi; Franca Tecchio
Journal:  Hum Brain Mapp       Date:  2010-10       Impact factor: 5.038

5.  No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab.

Authors:  Monica Margoni; Francesca Rinaldi; Alice Riccardi; Silvia Franciotta; Paola Perini; Paolo Gallo
Journal:  J Neurol       Date:  2019-09-27       Impact factor: 4.849

6.  Dual-Tasking in Multiple Sclerosis - Implications for a Cognitive Screening Instrument.

Authors:  Christian Beste; Moritz Mückschel; Madlen Paucke; Tjalf Ziemssen
Journal:  Front Hum Neurosci       Date:  2018-01-31       Impact factor: 3.169

7.  Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability.

Authors:  Antonio Giorgio; Jian Zhang; Maria Laura Stromillo; Francesca Rossi; Marco Battaglini; Lucia Nichelli; Marzia Mortilla; Emilio Portaccio; Bahia Hakiki; Maria Pia Amato; Nicola De Stefano
Journal:  Front Neurol       Date:  2017-11-14       Impact factor: 4.003

Review 8.  Neuroplasticity and functional recovery in multiple sclerosis.

Authors:  Valentina Tomassini; Paul M Matthews; Alan J Thompson; Daniel Fuglø; Jeroen J Geurts; Heidi Johansen-Berg; Derek K Jones; Maria A Rocca; Richard G Wise; Frederik Barkhof; Jacqueline Palace
Journal:  Nat Rev Neurol       Date:  2012-11-05       Impact factor: 42.937

9.  Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?

Authors:  Joachim Havla; Thivya Pakeerathan; Kevin Rostasy; Ilya Ayzenberg; Carolin Schwake; Jeffrey L Bennett; Ingo Kleiter; Ana Felipe-Rucián; Stephanie C Joachim; Amelie S Lotz-Havla; Tania Kümpfel; Markus Krumbholz; Eva M Wendel; Markus Reindl; Charlotte Thiels; Thomas Lücke; Kerstin Hellwig; Ralf Gold
Journal:  J Neuroinflammation       Date:  2021-05-29       Impact factor: 8.322

10.  The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.

Authors:  Francesco Fera; Luca Passamonti; Antonio Cerasa; Maria Cecilia Gioia; Maria Liguori; Ida Manna; Paola Valentino; Aldo Quattrone
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.